Wednesday, December 20, 2017 1:45:36 PM
https://ih.advfn.com/p.php?pid=nmona&article=76325126
CEO to submit filings this week to go current!
"today announced that it has nearly completed more than two years of financial statements and other related documents necessary to complete its listing upgrade to pink current status on OTC Markets.
Today UCL is finishing its financial statements and initial disclosure document as required by OTC Markets in order to complete the upgrade of its stock listing to pink current information status. UCL expects to be able to file these documents, pending legal review, in the next week or so. At such time UCL will immediately reschedule its shareholder conference call to review its current projects and ventures as summarized below:
Block Chain Project - UCL is currently is the process of designing and building a personal health records (PHR) block chain based business. The new platform will enable patients to gain control over their personal health records as well as who sees them, and how they are used. Expected beta launch for this project is Q1 2018."
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM